HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,010.00
-165.00 (-5.20%)
Oct 12, 2026, 3:30 PM KST

HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 265.3 billion as of October 12, 2026. It is the 21,300th most valuable company in the world and the 753rd biggest in South Korea. Its market cap has increased by 6.01% in one year.

Market Cap
265.30B
Enterprise Value
317.56B
Revenue
64.45B
Global Rank
Country Rank
#753 South Korea
PE Ratio
n/a

Chart

Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 265.30B, an increase of 150.74%. That is a compound annual growth rate of 5.71%.

History

DateMarket Cap% Change
Oct 12, 2026265.30B5.33%
Dec 30, 2025251.87B-73.05%
Dec 30, 2024934.49B182.02%
Dec 28, 2023331.36B-9.25%
Dec 29, 2022365.14B-3.64%
Dec 30, 2021378.91B-51.22%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
GC Corp.443.05B
Medy-Tox425.60B
Orum Therapeutics419.18B
MEDIPOST374.83B
SillaJen324.22B
Genomictree277.85B
GC Genome233.43B
GC Cell219.40B
Market Cap Rankings